|
|
||||||||
Ann Thorac Surg 1997;63:1206-1207
© 1997 The Society of Thoracic Surgeons
As Originally Published in 1988:
Updated in 1997 by Gregory D. Trachiotis, MD, Luca A. Vricella, MD, Benjamin L. Aaron, MD, and William R. Hix, MD
Division of Cardiothoracic Surgery, Department of Surgery, The George Washington University Medical Center, Washington, DC
Reexpansion pulmonary edema (RPE) remains a rare complication that occurs when a collapsed lung is rapidly reexpanded by evacuation of air or fluid. Since our review of the reported world experience with 47 cases of RPE between 1958 and 1987 [1], we have seen about 1 case per 2 years at our institution. Eighty-three percent of cases of RPE are a result of a chronically collapsed lung from a pneumothorax, and 83% are on the affected side; 6.7% are bilateral, and a few can occur in the contralateral lung. The onset of RPE occurs as rapidly as 1 hour in 64% of cases, and uniformly results in 24 hours. Although it is likely that rapid reexpansion by application of negative pressure contributes to RPE, it can occur in more than 33% of cases when reexpansion is allowed without pleural suction. The mortality remains about 20%, and seems to be associated with bilaterality and sudden onset of RPE [1].
The pathophysiology of RPE remains undefined, although there have been thoughtful reports in the experimental and clinical arenas [25]. The common end-point in the pathological process likely results from enhanced endothelial permeability [4,5]. This destructive process is thought to be a result of combined alveolar-capillary membrane disruption and ischemia-reperfusionmediated injury. These processes are likely to be initiated by the stretching or distention and increased pulmonary flow that occur during pulmonary reexpansion [5]. Once there is microvascular injury, the pathologic process is believed to propagate and worsen by local cellular imbalances in nitric oxide levels and by-products [4], neutrophil aggregation and degranulation [2,3], and free-radicalmediated tissue necrosis. The pathologic mechanism premised to be the basis of RPE is similar to that observed in the adult respiratory distress syndrome [4,5], postpneumonectomy pulmonary edema [5], and after pulmonary reimplantation.
The mainstay in therapy for RPE remains oxygenation, a low threshold for mechanical ventilation with positive end-expiratory pressure, diuresis, and hemodynamic support. With the recent data regarding the pathologic processes occurring in RPE, we have used the prostaglandin analogue misoprostil and ibuprofin or indocin suppositories once the diagnosis is suspected and early in therapy. The rationale for the use of these agents is based on either their cytoprotective or their antiinflammatory actions. Perhaps even more therapeutic is positioning the patient in the lateral decubitus position with the affected side up. This position may help reduce edema and intrapulmonary shunting. We continue to allow gradual lung expansion on underwater seal, and apply pleural suction once the lung is nearly expanded. Reexpansion pulmonary edema usually resolves in 24 to 72 hours.
In patients with bullous disease or young patients with a difficult recovery, there should be consideration of bullectomy or pleurodesis. We have also observed an increasing number of patients with acquired immunodeficiency syndromerelated pneumothoraces that are at risk for RPE. These patients are best managed with tube thoracostomy or a Heimlich valve [6].
Reexpansion pulmonary edema can occur unexpectedly and dramatically. Physicians who are called to treat a pneumothorax or hydrothorax should be aware of this phenomenon. Efforts should be made to reduce its occurrence or ameliorate the pathologic responses. Despite a growing understanding of the pathologic mechanism involved in RPE, a 20% mortality can be expected.
Footnotes
Address reprint requests to Dr Trachiotis, Division of Cardiothoracic Surgery, George Washington University Medical Center, 2150 Pennsylvania Ave, NW, Washington, DC 20037
References
This article has been cited by other articles:
![]() |
B. Baez and M. Castillo Anesthetic Considerations for Lung Transplantation Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2008; 12(2): 122 - 127. [Abstract] [PDF] |
||||
![]() |
N. Barbetakis, G. Samanidis, D. Paliouras, and C. Tsilikas Re-expansion pulmonary edema following video-assisted thoracic surgery for recurrent malignant pleural effusion Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 532 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Feller-Kopman, D. Berkowitz, P. Boiselle, and A. Ernst Large-Volume Thoracentesis and the Risk of Reexpansion Pulmonary Edema Ann. Thorac. Surg., November 1, 2007; 84(5): 1656 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Thomsen, J. DeLaPena, and G. S. Setnik Thoracentesis. N. Engl. J. Med., October 12, 2006; 355(15): e16 - e16. [PDF] |
||||
![]() |
S. Suzuki, H. Niikawa, J. Shibuya, T. Hosaka, S. Maeda, T. Suzuki, and M. Handa Analysis of edema fluids and histologic features of the lung in reexpansion pulmonary edema during video-assisted thoracoscopic surgery J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 387 - 389. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |